Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc. (IKT)

Market is closed
Latest 13D & 13G Filings
Company Symbol Filed By Filing Date Filing
Inhibikase Therapeutics Inc.
IKT
 Fairmount Funds Management LLC 2025-02-14
13G Filing
Inhibikase Therapeutics Inc.
IKT
Armistice Capital
 2025-02-14
13G Filing
Inhibikase Therapeutics Inc.
IKT
Point72 Asset Management
 2025-02-14
13G Filing
Inhibikase Therapeutics Inc.
IKT
Nantahala Capital Management
 2025-02-14
13G Filing
Inhibikase Therapeutics Inc.
IKT
ADAR1 Capital Management
 2025-02-14
13G Filing
Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)